Author's reply. "Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment".

Autor: Meijide Míguez H; Department of Internal Medicine, Hospital Quironsalud A Coruña, A Coruña, Spain., Montes García I; Executive Director, Residencia Dulcinea, Grupo Quirónsalud, Alcázar de San Juan, Ciudad. Real, Spain., Ochando Gómez M; Technical Director of Clinical Laboratory, Health Diagnostic, Grupo Quironsalud, Madrid, Spain., García Merino IM; Department of Research and Innovation, Grupo Quirónsalud, Madrid, Spain., Cano EL; Research Centre for Intelligent Information Technologies (CETINIA-DSLAB), Rey Juan Carlos University, Móstoles, Spain; Quantitative Methods and Socio-economic Development Group, Institute for Regional Development (IDR), University of Castilla-La Mancha (UCLM), Albacete, Spain., De La Torre A; Scientific Director, Clinica Imbanaco, Grupo Quironsalud, Cali, Valle del Cauca, Colombia. Electronic address: alejandro.delatorre@imbanaco.com.co.
Jazyk: angličtina
Zdroj: Revista espanola de geriatria y gerontologia [Rev Esp Geriatr Gerontol] 2023 May-Jun; Vol. 58 (3), pp. 175. Date of Electronic Publication: 2023 Apr 27.
DOI: 10.1016/j.regg.2023.04.003
Databáze: MEDLINE